| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Travere Therapeutics, Inc. (TVTX) has 8 insiders with recent SEC Form 4 filings, including 0 buys and 18 sells. TVTX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 432.9K | $23.29M | - | |
| Other | 138.6K | $7.46M | - | |
| Other | 123.1K | $6.62M | - | |
| CFO | 116.9K | $6.29M | - | |
| Other | 111.5K | $6.00M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Feb 3, 2021 | Dube Eric M57 | Chief Executive Officer | Sell | 2,406 | $28.91 | $69,557.46 | -1.6% | |
| Feb 3, 2021 | Rosenberg Noah L. | Chief Medical Officer | Sell | 1,813 | $28.91 | $52,413.83 | -2.0% | |
| Feb 3, 2021 | Rote William E.58 | Senior Vice President, R&D | Sell | 3,625 | $28.91 | $104,798.75 | -4.6% | |
| Feb 3, 2021 | Heerma Peter53 | Chief Commercial Officer | Sell | 1,126 | $29.83 | $33,588.58 | -1.0% | |
| Feb 2, 2021 | Aselage Steve80 | Director | Sale+OE | 25,000 | $30.75 | $768,750.00 | -11.3% | |
| Feb 2, 2021 | Rosenberg Noah L. | Chief Medical Officer | Sell | 1,813 | $30.75 | $55,749.75 | -1.9% | |
| Feb 2, 2021 | Rote William E.58 | Senior Vice President, R&D | Sell | 3,625 | $30.75 | $111,468.75 | -4.1% | |
| Feb 2, 2021 | Reed Elizabeth E58 | SVP, GC &Corporate Secretary | Sell | 3,175 | $30.75 | $97,631.25 | -3.7% | |
| Feb 2, 2021 | Dube Eric M57 | Chief Executive Officer | Sell | 8,734 | $29.91 | $261,266.72 | -2.8% | |
| Feb 2, 2021 | Clague Laura64 | Chief Financial Officer | Sell | 3,625 | $30.75 | $111,468.75 | -4.7% |